Using CICS-1 and SPM-011 and ï¼»18Fï¼½FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA
Stella Pharma Corporation
Stella Pharma Corporation
Numab Therapeutics AG
Telix Pharmaceuticals (Innovations) Pty Limited
Prelude Therapeutics
Ipsen
Quadriga Biosciences, Inc.
INSYS Therapeutics Inc